Cargando…
Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis
BACKGROUND: Sickle cell anemia (SCA) is associated with a chronic proinflammatory state characterized by elevated leukocyte count, mortality from severe recurrent infections, and subsequent vasoocclusive complications with leukocyte adhesion to the endothelium and increased plasma levels of inflamma...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199620/ https://www.ncbi.nlm.nih.gov/pubmed/32411797 http://dx.doi.org/10.1155/2020/4585704 |
_version_ | 1783529182845730816 |
---|---|
author | Garcia, Nadja Pinto Júnior, Alexander Leonardo S. Soares, Geyse Adriana S. Costa, Thainá Cristina C. dos Santos, Alicia Patrine C. Costa, Allyson Guimarães Tarragô, Andréa Monteiro Martins, Rejane Nina do Carmo Leão Pontes, Flávia de Almeida, Emerson Garcia de Paula, Erich Vinícius Martins-Filho, Olindo Assis Malheiro, Adriana |
author_facet | Garcia, Nadja Pinto Júnior, Alexander Leonardo S. Soares, Geyse Adriana S. Costa, Thainá Cristina C. dos Santos, Alicia Patrine C. Costa, Allyson Guimarães Tarragô, Andréa Monteiro Martins, Rejane Nina do Carmo Leão Pontes, Flávia de Almeida, Emerson Garcia de Paula, Erich Vinícius Martins-Filho, Olindo Assis Malheiro, Adriana |
author_sort | Garcia, Nadja Pinto |
collection | PubMed |
description | BACKGROUND: Sickle cell anemia (SCA) is associated with a chronic proinflammatory state characterized by elevated leukocyte count, mortality from severe recurrent infections, and subsequent vasoocclusive complications with leukocyte adhesion to the endothelium and increased plasma levels of inflammatory cytokines. The immune system has a close connection with morbidity in SCA, but further studies are needed to uncover the involvement of innate and adaptive immunities in modulating the SCA physiopathology. We performed measurements of the frequency of innate and adaptive immunity cells, cytokines, chemokines, and growth factors and immunophenotyping of Toll-like receptor and adhesion molecule expression in the blood of SCA patients and healthy donors to evaluate the different profiles of these biomarkers, the relationship among them, and their correlation to laboratory records and death risk. Material and Methods. Immunophenotyping of cells, Toll-like receptors, and adhesion molecules were performed from peripheral blood samples of SCA patients and healthy donors by flow cytometry and cytokine/chemokine/growth factor measurement by the Luminex technique performed from the serum of the same subjects. RESULTS: Cells of adaptive immunity such as IL-12, IL-17, and IL-10 cytokines; IL-8, IP-10, MIP-1α, MIP-1β, and RANTES chemokines; and VEGF, FGF-basic, and GM-CSF growth factors were higher in SCA patients than healthy donors regardless of any laboratorial and clinical condition. However, high death risk appears to have relevant biomarkers. CONCLUSION: In the SCA pathophysiology at steady state, there is a broad immunological biomarker crosstalk highlighted by TCD4+CD69+ lymphocytes, IL-12 and IL-17 inflammatory and IL-10 regulatory cytokines, MIP-1α, MIP-1β, and IP-10 chemokines, and VEGF growth factor. High expression of TLR2 in monocytes and VLA-4 in TCD8+ lymphocytes and high levels of MIP-1β and RANTES appear to be relevant in high death risk conditions. The high reticulocytosis and high death risk conditions present common correlations, and there seems to be a balance by the Th2 profile. |
format | Online Article Text |
id | pubmed-7199620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-71996202020-05-14 Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis Garcia, Nadja Pinto Júnior, Alexander Leonardo S. Soares, Geyse Adriana S. Costa, Thainá Cristina C. dos Santos, Alicia Patrine C. Costa, Allyson Guimarães Tarragô, Andréa Monteiro Martins, Rejane Nina do Carmo Leão Pontes, Flávia de Almeida, Emerson Garcia de Paula, Erich Vinícius Martins-Filho, Olindo Assis Malheiro, Adriana J Immunol Res Research Article BACKGROUND: Sickle cell anemia (SCA) is associated with a chronic proinflammatory state characterized by elevated leukocyte count, mortality from severe recurrent infections, and subsequent vasoocclusive complications with leukocyte adhesion to the endothelium and increased plasma levels of inflammatory cytokines. The immune system has a close connection with morbidity in SCA, but further studies are needed to uncover the involvement of innate and adaptive immunities in modulating the SCA physiopathology. We performed measurements of the frequency of innate and adaptive immunity cells, cytokines, chemokines, and growth factors and immunophenotyping of Toll-like receptor and adhesion molecule expression in the blood of SCA patients and healthy donors to evaluate the different profiles of these biomarkers, the relationship among them, and their correlation to laboratory records and death risk. Material and Methods. Immunophenotyping of cells, Toll-like receptors, and adhesion molecules were performed from peripheral blood samples of SCA patients and healthy donors by flow cytometry and cytokine/chemokine/growth factor measurement by the Luminex technique performed from the serum of the same subjects. RESULTS: Cells of adaptive immunity such as IL-12, IL-17, and IL-10 cytokines; IL-8, IP-10, MIP-1α, MIP-1β, and RANTES chemokines; and VEGF, FGF-basic, and GM-CSF growth factors were higher in SCA patients than healthy donors regardless of any laboratorial and clinical condition. However, high death risk appears to have relevant biomarkers. CONCLUSION: In the SCA pathophysiology at steady state, there is a broad immunological biomarker crosstalk highlighted by TCD4+CD69+ lymphocytes, IL-12 and IL-17 inflammatory and IL-10 regulatory cytokines, MIP-1α, MIP-1β, and IP-10 chemokines, and VEGF growth factor. High expression of TLR2 in monocytes and VLA-4 in TCD8+ lymphocytes and high levels of MIP-1β and RANTES appear to be relevant in high death risk conditions. The high reticulocytosis and high death risk conditions present common correlations, and there seems to be a balance by the Th2 profile. Hindawi 2020-01-08 /pmc/articles/PMC7199620/ /pubmed/32411797 http://dx.doi.org/10.1155/2020/4585704 Text en Copyright © 2020 Nadja Pinto Garcia et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Garcia, Nadja Pinto Júnior, Alexander Leonardo S. Soares, Geyse Adriana S. Costa, Thainá Cristina C. dos Santos, Alicia Patrine C. Costa, Allyson Guimarães Tarragô, Andréa Monteiro Martins, Rejane Nina do Carmo Leão Pontes, Flávia de Almeida, Emerson Garcia de Paula, Erich Vinícius Martins-Filho, Olindo Assis Malheiro, Adriana Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis |
title | Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis |
title_full | Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis |
title_fullStr | Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis |
title_full_unstemmed | Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis |
title_short | Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis |
title_sort | sickle cell anemia patients display an intricate cellular and serum biomarker network highlighted by tcd4+cd69+ lymphocytes, il-17/mip-1β, il-12/vegf, and il-10/ip-10 axis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199620/ https://www.ncbi.nlm.nih.gov/pubmed/32411797 http://dx.doi.org/10.1155/2020/4585704 |
work_keys_str_mv | AT garcianadjapinto sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis AT junioralexanderleonardos sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis AT soaresgeyseadrianas sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis AT costathainacristinac sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis AT dossantosaliciapatrinec sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis AT costaallysonguimaraes sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis AT tarragoandreamonteiro sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis AT martinsrejanenina sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis AT docarmoleaopontesflavia sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis AT dealmeidaemersongarcia sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis AT depaulaerichvinicius sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis AT martinsfilhoolindoassis sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis AT malheiroadriana sicklecellanemiapatientsdisplayanintricatecellularandserumbiomarkernetworkhighlightedbytcd4cd69lymphocytesil17mip1bil12vegfandil10ip10axis |